Supporting Patients
Living With PFS, PAS & PSSD

SIDEfxHUB is a UK-registered charity supporting patients affected by Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction through research, advocacy, and community.

11,557 finasteride reports to FDA FAERS · 21,287 finasteride reports to WHO VigiBase from 153 countries · 2019 EMA recognised that SSRI sexual dysfunction may persist · 3,764 genes showed altered expression in PFS patients· 2021 Post-Finasteride Syndrome added as a MedDRA term· 94% of surveyed PFS patients report low libido· 524 patients have joined the SIDEfxHUB registry· 11,557 finasteride reports to FDA FAERS · 21,287 finasteride reports to WHO VigiBase from 153 countries · 2019 EMA recognised that SSRI sexual dysfunction may persist · 3,764 genes showed altered expression in PFS patients· 2021 Post-Finasteride Syndrome added as a MedDRA term· 94% of surveyed PFS patients report low libido· 524 patients have joined the SIDEfxHUB registry·

Join Our WhatsApp Peer Support Groups

Our groups are currently active in the following regions: UK, US & Canada, Benelux/France/Italy and Scandinavia.

The Conditions

Three medicines. One shared patient experience.

Documented in peer-reviewed research and recognised by the FDA and EMA — yet still widely under-recognised in everyday clinical practice.

1

A routine prescription

Hair loss. Anxiety. Acne. Patients went to their doctors for common conditions and were prescribed FDA-approved medications taken by tens of millions worldwide.

2

Side effects described as rare and reversible

Product labelling described side effects as uncommon and reversible on discontinuation. Patients and prescribers alike understood them to be temporary.

3

They stopped the medication. The symptoms didn't stop.

Persistent sexual dysfunction. Cognitive difficulties. Emotional blunting. For some patients the symptoms continued long after the medication was discontinued.

4

Recognition is still catching up

Labels have since been updated and research is under way. But these conditions remain uncommon and underreported, and are not yet a routine part of medical training — which is why we work alongside clinicians and researchers to close that gap.

Post Finasteride Syndrome

Finasteride / Propecia

Prescribed for male pattern hair loss and enlarged prostate. A minority of patients report sexual, cognitive and emotional symptoms that persist after stopping the medication.

Learn more →

PSSD

SSRIs / Antidepressants

Among the world's most prescribed antidepressants. Some patients experience persistent sexual dysfunction and emotional blunting that continues after treatment ends.

Learn more →

Post-Accutane Syndrome

Isotretinoin / Accutane

Prescribed for severe acne. Some patients report sexual, cognitive and emotional symptoms that continue long after the course of treatment is completed.

Learn more →

Donate to PFS & PSSD Research

Support ongoing research into PFS & PSSD. As a neutral charity, we facilitate direct donations to research studies and provide links to other relevant websites, where appropriate. Thank you for your consideration.

About SIDEfxHUB

Welcome to SIDEfxHUB, a charity dedicated to improving the lives of those impacted by PSSD and PFS. We believe in the power of collective action and are committed to connecting communities to amplify their voices. Our mission is to provide a platform for shared fundraising, support credible research, and enhance patient support through various initiatives.

Join us in our efforts to make a meaningful difference. Whether through donating, participating in our registry, or staying informed with our updates, your involvement is invaluable in moving our cause forward.

Learn more about us →

Current Initiatives

WhatsApp Peer Support Groups

Join our peer support WhatsApp groups to connect with others who understand what you are going through. Whether you are dealing with PFS, PSSD, or other medication-related challenges, our supportive community is here to help. Share experiences, ask questions, and find comfort among peers. Join us on WhatsApp today.

PSSD & PFS Registry

The PSSD & PFS Registry links individuals with specific conditions to researchers conducting relevant studies. By joining, you aid in advancing medical research while ensuring your privacy and informed consent. Contribute to the development of new treatments by registering today. Join the registry.

Scientific Medical Research

We are committed to supporting those affected by PFS and PSSD, conditions caused by adverse medication effects. Our mission is to advance research and provide vital support. By working with leading researchers, we aim to find effective treatments and raise awareness. Your support is essential. Donate now.

PFS & PSSD Patient Registry

Join the Registry

Help build the world's largest patient database for PFS and PSSD. Your participation drives research and recognition.

0
Patients registered
0
Countries represented
0
Studies in progress

Why join?

Drive research forward

Your data directly supports the Milano Project and other research efforts.

Stay informed

Receive updates on research breakthroughs and community initiatives.

Show the true scale

Help researchers and regulators understand how many people these conditions affect worldwide.

"For years, I felt like my struggles were invisible. A united registry is the first step toward being truly seen."

— PSSD Patient, Germany

Join the registry

It takes about 3 minutes, and you can stay anonymous.

  • Open to anyone affected by PFS, PAS or PSSD
  • Stored securely, never shared without your consent
  • Remove your data at any time, no questions asked
Start registration →

Secure · GDPR-compliant · UK charity 1203385

If you are in crisis: 988 Lifeline (US) | 116 123 Samaritans (UK) | Find a helpline